Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Clinical trial NCT02289417 · COMPLETED
Trial details
- NCT number
- NCT02289417
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-08
- Primary completion
- 2017-09-25
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.